PDE5 inhibitor compositions and methods for treating cardiac indications
AssigneeThe Johns Hopkins University
InventorsDavid Kass, Eiki Takimoto, Hunter Champion
Life of this patent
Estimating the term…
Abstract
The invention features methods and compositions featuring a PDE5 inhibitor for treating or preventing a cardiac indication in a subject.
Claims13
A method of enhancing cardiac function in a subject having left ventricular hypertrophy, the method comprising administering to the subject an effective amount of a PDE5 inhibitor, wherein the administration of the inhibitor enhances cardiac function.
A method of reducing left ventricular hypertrophy in a subject having left ventricular hypertrophy, the method comprising administering to the subject an effective amount of a PDE5 inhibitor, wherein the administration of the inhibitor reduces cardiac hypertrophy.
A method of reversing left ventricular cardiac hypertrophy in a subject, the method comprising administering to a subject identified as having left ventricular cardiac hypertrophy an effective amount of a PDE5 inhibitor, wherein the administration of the inhibitor reverses left ventricular cardiac hypertrophy.
Dependencies are inferred from the claim text.